Stockscreener 앱 받기
1.20
0.00%
0.00
시장 영업 전:
.90
-0.30
-25.00%
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam slips 12%, prices $10M stock offering - MSN
HeartBeam prices $10M public offering at $0.80 per share By Investing.com - Investing.com India
HeartBeam’s first customer joins insiders in $10M stock sale - Stock Titan
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock - Business Wire
HeartBeam announces stock offering; shares drop 18% after-hours - MSN
HeartBeam launches public offering of common stock - Investing.com
HeartBeam launches public offering of common stock By Investing.com - Investing.com India
HeartBeam (NASDAQ: BEAT) seeks funding with [●]‑share offering and pre‑funded warrants - Stock Titan
Heartbeam announces proposed public offering of common stock - marketscreener.com
Heartbeam Announces Proposed Public Offering Of Common Stock - TradingView — Track All Markets
HeartBeam Announces Proposed Public Offering of Common Stock - Business Wire
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 earnings call transcript - MSN
Aug Chart Watch: Will HeartBeam Inc benefit from rising consumer demand2026 Technicals & Verified Momentum Stock Ideas - baoquankhu1.vn
HeartBeam Faces Competitive Landscape as Medical Tech Rivals Vie for Market Share - National Today
Block Trades: Will HeartBeam Inc benefit from rising consumer demand2026 Trade Ideas & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam's (BEAT) 'Significant Turning Point' Spotlighted in Recent Article - NewMediaWire
BEAT Stock Price, Quote & Chart | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill
BEAT SEC FilingsHeartbeam Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HeartBeam’s (NASDAQ: BEAT) ‘Significant Turning Point’ Spotlighted in Recent Article - TradingView — Track All Markets
Sectors Review: Should value investors consider HeartBeam Inc2026 Analyst Calls & Real-Time Volume Analysis Alerts - baoquankhu1.vn
HeartBeam Reaches 'Significant Turning Point' After FDA Clearance - National Today
B. Riley Securities Initiates Coverage on HeartBeam (BEAT) with Buy Rating | BEAT Stock News - GuruFocus
B. Riley Securities Initiates HeartBeam(BEAT.US) With Buy Rating, Announces Target Price $4 - moomoo.com
B.Riley initiates Heartbeam stock coverage with buy rating on FDA clearance - Investing.com
Aug Sentiment: What analysts say about HeartBeam Inc stock2026 Retail Activity & Low Drawdown Trading Strategies - baoquankhu1.vn
D. Boral Capital initiates Heartbeam stock coverage with buy rating By Investing.com - Investing.com India
This Honeywell Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Benzinga
D. Boral Capital initiates Heartbeam stock coverage with buy rating - Investing.com
HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and Validation - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation - Digital Journal
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - USA Today
HeartBeam (NASDAQ: BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates - USA Today
HeartBeam (BEAT) director receives 44,827-share stock option grant at $1.43 - Stock Titan
HeartBeam (BEAT) CFO receives stock options on 53,104 shares at $1.45 - Stock Titan
HeartBeam (BEAT) awards director Richard Ferrari 50,000 RSUs - Stock Titan
HeartBeam (BEAT) awards 41,380-share stock option grant to major holder - Stock Titan
HeartBeam (BEAT) director awarded 20,689 RSUs, holdings rise to 95,809 shares - Stock Titan
HeartBeam (BEAT) president receives 61,932-share stock option grant at $1.45 - Stock Titan
HeartBeam (BEAT) director receives 51,724 options at $1.43 exercise price - Stock Titan
HeartBeam (BEAT) director receives 17,241 RSUs in equity grant - Stock Titan
Director at HeartBeam (NASDAQ: BEAT) receives option grant for 51,724 shares - Stock Titan
HeartBeam (BEAT) president receives 55,172 stock options as equity grant - Stock Titan
Aug Opening: Can HeartBeam Inc outperform in the next rallyTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
If You Invested $1,000 in Heartbeam Inc (BEAT) - Stock Titan
HeartBeam announces first patient enrollments in heart attack detection pilot study - MSN
HeartBeam : Earnings Documents - MarketScreener
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today
Aug Catalysts: Is HeartBeam Inc Equity Warrant benefiting from interest rate changesMarket Activity Report & Community Trade Idea Sharing - baoquankhu1.vn
Trend Recap: Is HeartBeam Inc a turnaround storyWeekly Trade Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
H.C. Wainwright reiterates Heartbeam stock rating on commercial progress By Investing.com - Investing.com India
H.C. Wainwright reiterates Heartbeam stock rating on commercial progress - Investing.com
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam Shares Fall After Benchmark Maintains Speculative Buy Rating - marketscreener.com
Benchmark Maintains HeartBeam's Rating at Speculative Buy, Price Target is $8 - marketscreener.com
0.48%
1.81%
자본화:
|
볼륨(24시간):